Iowa PBM Law: New Restrictions & Changes
- Iowa is the latest state to address the role of pharmacy benefit managers (PBMs) in prescription drug costs.
- Senate File 383 includes provisions to prevent PBMs from steering patients to specific pharmacies and seeks to equalize reimbursement rates.
- However, the new regulations on pharmacy benefit managers have raised concerns.
Iowa takes decisive action regarding prescription drug costs. Governor Kim Reynolds signed legislation limiting the influence of pharmacy benefit managers (PBMs), aiming to protect rural pharmacies and lower consumer expenses.This landmark iowa PBM law, Senate File 383, seeks to equalize reimbursement rates and prevent patient steering. While proponents champion increased transparency,some experts raise concerns about potential cost increases for health plans and patients. The legislation’s primary_keyword impact is keenly felt, and the new regulations on pharmacy benefit managers have stirred a secondary_keyword debate. The Iowa Pharmacy Association believes the law supports access to care in underserved areas. News directory 3 sheds light on thes crucial developments, and the governance will closely monitor financial consequences. discover what’s next as Iowa navigates these changes.
Iowa Law Aims to Rein In Pharmacy Benefit Managers, Sparks Cost Debate
Updated June 17, 2025
Iowa is the latest state to address the role of pharmacy benefit managers (PBMs) in prescription drug costs. Gov. Kim Reynolds recently signed legislation designed to limit the influence of these drug middlemen, a move intended to protect rural pharmacies and lower consumer expenses. The new law places limits on pharmacy benefit managers.
Senate File 383 includes provisions to prevent PBMs from steering patients to specific pharmacies and seeks to equalize reimbursement rates. Reynolds said the law targets PBMs’ “outsized control” over the pharmaceutical supply chain by reforming payment structures and ensuring fair practices. the goal is to increase transparency and competition in the pharmaceutical market, giving pharmacies more power to appeal PBM decisions.
However, the new regulations on pharmacy benefit managers have raised concerns. Some experts suggest the changes could lead to higher costs for both health plans and patients. The Iowa Association of Business and Industry, which lobbied against the bill, warned of potential financial repercussions for businesses and employees.
Advocates for the law, like Kate Gainer, CEO of the Iowa Pharmacy Association, argue it will help keep small, rural pharmacies afloat. Gainer said more than 30 rural Iowa pharmacies have closed as last year, a number that climbs to over 200 over the past decade. She believes the law provides tools to level the playing field and protect access to care, especially in underserved areas.
Reynolds acknowledged the cost concerns, calling the decision to sign the bill “arduous.” Her administration plans to monitor implementation closely to mitigate any unintended consequences for private employers.
“Governor Reynolds’ leadership and the Iowa Legislature’s bipartisan support of SF 383 sends a powerful message that the health of Iowa communities comes first,” Gainer said.
What’s next
The Iowa administration will monitor the effects of the new law on pharmacy benefit managers, especially focusing on its impact on healthcare costs for businesses and individuals. Further adjustments may be considered to address any unintended financial burdens.